Author:
Hashizume Hideki,Adachi Hayamitsu,Igarashi Masayuki,Nishimura Yoshio,Akamatsu Yuzuru
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology
Reference15 articles.
1. Spangler, S. K., Jacobs, M. R. & Appelbaum, P. C. Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinone (U-100592 and U-100766), and other oral and parental agents against 203 penicillin-susceptible and -resistant Pneumococci. Antimicrob. Agents Chemother. 40, 481–484 (1996).
2. Robert, J. F. In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococci. Antimicrob. Agents Chemother. 35, 553–559 (1991).
3. George, M. E. et al. In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic. Antimicrob. Agents Chemother. 30, 532–535 (1986).
4. Peterson, P. J., Jacobus, N. V., Weiss, W. J., Sum, P. E. & Testa, R. T. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936). Antimicrob. Agents Chemother. 43, 738–744 (1999).
5. Lee, D. K. et al. Antimicrobial activity of mupirocin, daptomycin, linezolid, quinupristin/dalfopristin and tigecycline against vancomycin-resistant Enterococci (VRE) from clinical isolates in Korea (1998 and 2005). J. Biochem. Mole. Biol. 40, 881–887 (2007).
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献